Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Taysha Gene Therapies, Inc.

Submit an IND/CTA filing for one of the pipeline programs

Delivered by the deadline

Under re-examination This entry has been challenged and is being re-checked against the sources.

Announced
1 Feb 2021
Due
31 Dec 2021
Delivered
by 1 Jan 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Submit an IND/CTA filing for one of the five above-named programs in 2021”

What we found

Evidence strength A What the grades mean

The company submitted and received approval for a CTA filing for TSHA-118 in 2021, and also submitted a CTA filing for TSHA-102 in November 2021.

  • A
    Taysha Gene Therapies, Inc. 10-K filed 2022-03-31 Regulatory filing · published 31 Mar 2022 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint 4f77cdd738c2
    “For Rett syndrome, we submitted a CTA filing in November 2021” ✓ confirmed on the page
  • A
    Taysha Gene Therapies, Inc. 10-Q filed 2022-08-11 Regulatory filing · published 11 Aug 2022 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint 0154d22ce4cf
    “We submitted a CTA filing for TSHA-118 which was approved by Health Canada in 2021” ✓ confirmed on the page

Checked 25 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Regulatory filing
Indicative materiality
Medium rules
Action
Submit
Deliverable
IND/CTA filing
In the company’s control
Medium
Specificity
Medium
Depends on
Regulatory

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Taysha Gene Therapies, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-TSHA-022708 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.